Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension
Pulmonary arterial hypertension is a severe lung disease characterised by progressive vascular remodelling. Here, the authors show that reduced signalling of flow-activated transcription factor KLF2 is a common feature of human PAH and that KLF2-regulated exosomal miRNAs have a therapeutic effect.
Guardado en:
Autores principales: | Hebah A. Sindi, Giusy Russomanno, Sandro Satta, Vahitha B. Abdul-Salam, Kyeong Beom Jo, Basma Qazi-Chaudhry, Alexander J. Ainscough, Robert Szulcek, Harm Jan Bogaard, Claire C. Morgan, Soni S. Pullamsetti, Mai M. Alzaydi, Christopher J. Rhodes, Roberto Piva, Christina A. Eichstaedt, Ekkehard Grünig, Martin R. Wilkins, Beata Wojciak-Stothard |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4eebb969beec4b25a1d7906be6c74e47 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension
por: Hebah A. Sindi, et al.
Publicado: (2020) -
JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency
por: Yinghua Huang, et al.
Publicado: (2020) -
PA and OA induce abnormal glucose metabolism by inhibiting KLF15 in adipocytes
por: Cuizhe Wang, et al.
Publicado: (2021) -
KLF10 integrates circadian timing and sugar signaling to coordinate hepatic metabolism
por: Anthony A Ruberto, et al.
Publicado: (2021) -
Klf4 glutamylation is required for cell reprogramming and early embryonic development in mice
por: Buqing Ye, et al.
Publicado: (2018)